| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |